Humanscape builds and operates two core products: Mamitok, a pregnancy and early-childhood platform that partners with obstetrics and gynecology clinics to deliver ultrasound imaging, AI-based growth analytics, and curated information for expectant parents, and RareNote, a patient-centric platform that lets people with rare diseases manage medical records, estimate treatment costs, and track medications while contributing data for global clinical research and drug development. Mamitok has become a leading service in Korea and is seeing particularly strong user growth in the United States, Vietnam, and Indonesia. The company reports that its global revenue more than tripled year-over-year. Humanscape intends to leverage its growing data sets to develop additional AI-driven healthcare solutions and services. Looking ahead, management is pursuing international expansion, with a focus on the U.S. market, and is preparing for a KOSDAQ IPO in partnership with KB Securities. Cumulatively, the firm has raised 80 billion KRW in funding to date.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2025